Agcl Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 0.48 M
- Revenue Growth 81.14%
- Profit Growth 1845.05%
- Ebitda -811.26%
- Net Worth 2.83%
- Total Assets 66.50%
About Agcl Lifesciences
Agcl Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 December 2016 (Eight years and two months 15 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.48 M.
Govil Choure and Arpana Govil serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36900MH2016PTC288404
- Company No.
288404
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2016
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Agcl Lifesciences Private Limited offer?
Agcl Lifesciences Private Limited offers a wide range of products and services, including Electrical Panels & Distribution Box, Distribution Box, Street, Flood and Commercial Lights, Lighting Poles, Fuses, Circuit Breakers & Components, High Voltage Circuit Breakers, Electrical Conduits and Fittings, Cable Raceways, Industrial Control Panel.
Who are the key members and board of directors at Agcl Lifesciences?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Govil Choure ![]() | Director | 13-Dec-2016 | Current |
Arpana Govil ![]() | Director | 13-Dec-2016 | Current |
Financial Performance of Agcl Lifesciences.
Agcl Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 81.14% increase. The company also saw a substantial improvement in profitability, with a 1845.05% increase in profit. The company's net worth moved up by a moderate rise of 2.83%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Agcl Lifesciences?
In 2017, Agcl Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0.48 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.05 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
01 Feb 2021 | Indian Overseas Bank | ₹0.48 M | Open |
How Many Employees Work at Agcl Lifesciences?
Unlock and access historical data on people associated with Agcl Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Agcl Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agcl Lifesciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.